IDH2 and essential thrombocythemia: It was demonstrated that ASXL1, SRSF2, and IDH2 for PV and SH2B3, SF3B1, U2AF1, TP53, IDH2, and EZH2 for ET were associated with inferior survival, higher risk of leukemic, and fibrotic transformation.